INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← Cardiology / Health Desk

Chocolate and artery dilation: markers without event trials

A flavonoid review found chocolate-related vascular changes but no randomized evidence on cardiovascular morbidity or mortality.

Whole-food ingredients prepared without added oil

Illustrative food image, not a photograph of the study intervention.

A broad review with a crucial absence

This systematic review included 133 randomized controlled trials examining flavonoids, flavonoid-rich foods and cardiovascular risk measures. The investigators searched MEDLINE, EMBASE and Cochrane databases and assessed study validity before pooling findings. Despite the large overall trial count, no included randomized trial studied cardiovascular morbidity or mortality. That absence is central to interpreting the chocolate findings. The review can describe changes in flow-mediated dilatation, blood pressure and lipoproteins, but it cannot report a randomized reduction in cardiovascular events. The overall count of 133 also should not be mistaken for 133 chocolate trials; it covers the review's different foods and flavonoid categories.

Hooper L, Kroon PA, Rimm EB, Cohn JS et al.. The American journal of clinical nutrition, 2008. PMID 18614722 · DOI

Acute and chronic results are separate

Chocolate increased flow-mediated dilatation after acute intake by a reported 3.99%, with a 95% confidence interval from 2.86 to 5.12, across six studies. The chronic-intake estimate was 1.45%, with an interval from 0.62 to 2.28, based on only two studies. Those two estimates describe different time frames and different bodies of evidence. Neither should be relabeled as a percentage reduction in heart attacks. The abstract presents flow-mediated dilatation as a vascular risk measure, not a clinical outcome. Keeping the study counts beside the estimates also makes clear how small the chronic chocolate evidence base was within this much broader review.

Hooper L, Kroon PA, Rimm EB, Cohn JS et al.. The American journal of clinical nutrition, 2008. PMID 18614722 · DOI

Blood pressure provides another limited endpoint

The chocolate results included a systolic blood-pressure reduction of 5.88 mm Hg, with a 95% confidence interval from minus 9.55 to minus 2.21, across five studies. Diastolic pressure fell by 3.30 mm Hg, with an interval from minus 5.77 to minus 0.83, across four studies. These findings accompanied the vascular results but did not fill the review's gap in clinical-event trials. Significant heterogeneity across the wider analysis confirmed that foods and flavonoid subclasses had different effects. A single label such as flavonoid-rich therefore cannot justify assigning one food's pooled blood-pressure finding to every other food in the review.

Hooper L, Kroon PA, Rimm EB, Cohn JS et al.. The American journal of clinical nutrition, 2008. PMID 18614722 · DOI

Cocoa recipes are not equivalent interventions

The abstract identifies chocolate as the intervention category behind the flow-mediated dilatation and blood-pressure estimates, while the authors describe cocoa and soy as major areas of research attention. It does not provide a tested recipe for unsweetened cocoa powder or establish that a cocoa-containing dessert reproduces the chocolate results. A cocoa dessert is consequently a culinary pairing, not an evidence-based dose. The authors called for dose-response research and trials long enough to assess clinically relevant endpoints. That request fits the review's main boundary: favorable vascular measurements in small subsets of trials do not amount to demonstrated prevention of cardiovascular illness or death.

Hooper L, Kroon PA, Rimm EB, Cohn JS et al.. The American journal of clinical nutrition, 2008. PMID 18614722 · DOI